Seasonal influenza is associated with a heightened risk of hospitalization in pregnant women during all trimesters but not the postpartum period, with the risk varying by influenza type and ethnicity, a study has found.
Reduced caloric intake results in a significant improvement in glucose metabolism and body-fat composition, including liver-fat content, according to a study. Changes in ferritin levels appear to mediate the striking reduction in liver fat.
A significant association exists between tumour volume-related parameters and radical prostatectomy, suggests a study. However, these parameters do not add important discriminatory value to standard clinicopathological variable for radical prostatectomy prediction or provide benefit across a range of clinically relevant decision thresholds.
Use of neither eicosapentaenoic acid (EPA) nor aspirin results in fewer patients with at least one colorectal adenoma, according to data from the Systematic Evaluation of Aspirin and Fish Oil Polyp Prevention trial.
Using smartphone cameras for ophthalmic examination may result in variabilities in the objective quantification of conjunctival redness, highlighting the importance of camera calibration, a recent study has found.
N-acetylcysteine (NAC), sodium bicarbonate, ascorbic acid and statins appear to effectively prevent contrast-induced acute kidney injury in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention, according to a meta-analysis. Evidence is strongest for NAC, especially in patients requiring high-contrast doses.
It appears that attending cram school for ≥2 h/d increases the risk of children’s incident myopia, which may be caused by greater near visual activity or reduced time outdoors, suggests a recent Taiwan study.
Olanzapine confers a modest therapeutic effect on weight compared with placebo in adult outpatients with anorexia nervosa, a study has shown. However, it does not appear to offer significant benefit for psychological symptoms.
Treatment with secukinumab results in a higher rate of remission or low-disease activity at week 16 in patients with psoriatic arthritis as compared with placebo, according to a posthoc analysis of the FUTURE 2 study. This effect is sustained at 2 years and is evident in both tumour necrosis factor inhibitor-experienced and -naïve patients.